Final analysis of the MAGNOLIA trial: zanubrutinib in marginal zone lymphoma
Final analysis of the MAGNOLIA trial: zanubrutinib in
Final analysis of the MAGNOLIA trial: zanubrutinib in
Clinical findings with sundry targets in various B-cel
Follicular lymphoma: bispecific and PI3Kδ-targeted app
Biomarkers: predicting response to treatment
New approaches in relapsed and refractory DLBCL Pol
Advances in PSMA radiotracers for prostate cance
Advances in immunotherapy for neuroendocrine tum
Neuroendocrine tumor imaging updates Little
Latest developments in prostate cancer treatment
SSTR-positive neuroendocrine tumors: peptide rec